Quotient Liabilities 2024

Quotient Aktienanalyse

What does Quotient do?

Quotient Ltd is a biopharmaceutical company headquartered in Eysins, Switzerland. The company was founded in 2007 with the aim of developing innovative technologies in the field of Personalized Medicine. This means that medications and therapies are specifically tailored to the individual needs of patients. Thanks to state-of-the-art production processes, products can be produced quickly and safely. Quotient Ltd has a unique business model based on transfusion technology. This technology allows the company to produce medications quickly and accurately. The different components of the medications are separated and then combined in the required dosage. This means that the medications can be precisely dosed and the risks of side effects minimized. A key focus of Quotient Ltd is the development of therapeutics. Personalized medicine and the fast and safe production of medications are at the center of this area. The transfusion technology enables medications to be produced quickly and flexibly, which is particularly important for rare diseases and personalized therapies. Another important area is the development of diagnostics. These enable diseases to be diagnosed quickly and safely. Based on this diagnosis, suitable therapies are then developed. Quotient Ltd also relies on transfusion technology for this, which enables fast, reliable, and flexible production of diagnostics. In addition to its developed technology and know-how, Quotient Ltd also has its own production facility. Here, all products are produced to the highest standards. The production facility covers an area of approximately 6,000 square meters. The modern facility is equipped with the latest technologies and meets the highest quality standards. Quotient Ltd offers a variety of products, with a special focus on personalized medicine and the fast and safe production of medications and diagnostics. One example is the PDA diagnostic system, which was developed for the fast and accurate diagnosis of autoimmune diseases. The MosaiQ system is another important product that enables fast and reliable production of medications. The success story of Quotient Ltd is closely linked to the development of transfusion technology. The company has succeeded in developing a technology that allows for the fast and safe production of personalized medicine. This technology has made Quotient Ltd a leading company in the field of personalized medicine worldwide. Today, Quotient Ltd employs over 700 people who are constantly working on the further development of personalized medicine and transfusion technology. Quotient ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Quotient's Liabilities

Quotient's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Quotient's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Quotient's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Quotient's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Quotient’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Quotient stock

What is the level of liabilities of Quotient this year?

Quotient has a debt balance of 338.09 M USD this year.

What were the liabilities of Quotient compared to the previous year?

The liabilities of Quotient have increased by 32.38% increased compared to the previous year.

What are the consequences of high debt for investors of Quotient?

High liabilities can pose a risk for investors of Quotient, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Quotient?

Low liabilities mean that Quotient has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Quotient affect the company?

An increase in liabilities of Quotient can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Quotient affect the company?

A decrease in the liabilities of Quotient can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Quotient?

Some factors that can influence the liabilities of Quotient include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Quotient so important for investors?

The liabilities of Quotient are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Quotient take to modify the liabilities?

To change its liabilities, Quotient can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Quotient pay?

Over the past 12 months, Quotient paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Quotient is expected to pay a dividend of 0 USD.

What is the dividend yield of Quotient?

The current dividend yield of Quotient is .

When does Quotient pay dividends?

Quotient pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Quotient?

Quotient paid dividends every year for the past 0 years.

What is the dividend of Quotient?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Quotient located?

Quotient is assigned to the 'Health' sector.

Wann musste ich die Aktien von Quotient kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Quotient from 12/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/4/2024.

When did Quotient pay the last dividend?

The last dividend was paid out on 12/4/2024.

What was the dividend of Quotient in the year 2023?

In the year 2023, Quotient distributed 0 USD as dividends.

In which currency does Quotient pay out the dividend?

The dividends of Quotient are distributed in USD.